Literature DB >> 23807388

Are generic topical prostanoids the way forward in the care of glaucoma patients? - Yes.

L C Titcomb1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807388      PMCID: PMC3772358          DOI: 10.1038/eye.2013.124

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  8 in total

1.  An evaluation of therapeutic noninferiority of 0.005% latanoprost ophthalmic solution and xalatan in patients with glaucoma or ocular hypertension.

Authors:  Maurizio Digiuni; Gianluca Manni; Michele Vetrugno; Maurizio Uva; Giovanni Milano; Nicola Orzalesi; Paolo Fogagnolo; Marco Centofanti; Emilio Campos; Luca Rossetti
Journal:  J Glaucoma       Date:  2013-12       Impact factor: 2.503

2.  Comparative analysis of prednisolone acetate suspensions.

Authors:  Calvin W Roberts; Peter L Nelson
Journal:  J Ocul Pharmacol Ther       Date:  2007-04       Impact factor: 2.671

3.  Generic prednisolone suspension substitution.

Authors:  R G Fiscella; M Jensen; G Van Dyck
Journal:  Arch Ophthalmol       Date:  1998-05

4.  Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis.

Authors:  Sylvia L Hargrave; Jae Chang Jung; M Elizabeth Fini; Henry Gelender; Christian Cather; Anne Guidera; Ira Udell; Stephen Fisher; James V Jester; R Wayne Bowman; James P McCulley; H Dwight Cavanagh
Journal:  Ophthalmology       Date:  2002-02       Impact factor: 12.079

5.  Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs.

Authors:  N G Congdon; O D Schein; P von Kulajta; L H Lubomski; D Gilbert; J Katz
Journal:  J Cataract Refract Surg       Date:  2001-04       Impact factor: 3.351

6.  [Clinical trial of the generic product UNILAT following its efficiency and safety in glaucoma and intraocular hypertension].

Authors:  P Strmen; V Jancus; J Okkelová; M Tvrdonová
Journal:  Cesk Slov Oftalmol       Date:  2010-12

7.  A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension.

Authors:  Arun Narayanaswamy; Aditya Neog; M Baskaran; Ronnie George; Vijaya Lingam; Chetan Desai; Viraj Rajadhyaksha
Journal:  Indian J Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 1.848

8.  A patient with corneal epithelial disorder that developed after administration of a latanoprost generic, but not a brand-name drug, eye drop.

Authors:  Yukihisa Takada; Yuka Okada; Norihito Fujita; Shizuya Saika
Journal:  Case Rep Ophthalmol Med       Date:  2012-10-02
  8 in total
  2 in total

1.  Patient experience of the transition from Xalatan to generic latanoprost.

Authors:  S L Painter; A L Mead
Journal:  Eye (Lond)       Date:  2014-04-11       Impact factor: 3.775

Review 2.  The Use of Generic Medications for Glaucoma.

Authors:  Andrew J Tatham
Journal:  J Ophthalmol       Date:  2020-04-07       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.